When it comes to weight loss, GLP-1 medications like Wegovy and Mounjaro are gaining attention for their ability to help people shed 1520% of their body weight
Among those who voted yes was Kris Wusterhausen, a recent addition to the committee who is a doctor and the founder of a Texas wellness clinic that recommends peptides, including BPC-157
doi: 10.1016/j.pcd.2016.09.003 45 SavareseGSharmaAPangCWoodRGeorgeJTSoleymanlouN
The following findings are schematically represented in Figure 1
N Engl J Med 2017;377:644-57.ArticlePubMed 38
Baseline clinical characteristics enriched among super responders compared to the minimal response group included fibromyalgia (rate ratio [RR]: 0.2, p = 0.002) and osteoarthritis (RR: 0.5, p = 0.001) for Zepbound, and psoriasis (RR: 2.5, p = 0.03) for Wegovy